Friday, 16 October 2026European Markets

KLEPIERRE And MONTEA Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - klepierre (li.pa) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
klepierre (li.pa) €23.73 7.8% 1.26%
montea (mont.br) €79.20 4.13% 5.79%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. klepierre (li.pa)

7.8% forward dividend yield and 1.26% return on equity

klépierre is the european leader in shopping malls, combining property development and asset management skills. the company's portfolio is valued at €19.4 billion at june 30, 2023, and comprises large shopping centers in more than 10 countries in continental europe which together host hundreds of millions of visitors per year. klépierre holds a controlling stake in steen & strøm (56.1%), scandinavia's number one shopping center owner and manager. klépierre is a french reit (siic) listed on euronext paris and is included in the cac next 20 and epra euro zone indexes. it is also included in ethical indexes, such as euronext cac 40 esg, cac sbt 1.5, msci europe esg leaders, ftse4good, euronext vigeo europe 120, and features in cdp's "a-list". these distinctions underscore the group's commitment to a proactive sustainable development policy and its global leadership in the fight against climate change.

earnings per share

as for profitability, klepierre has a trailing twelve months eps of €0.6.

pe ratio

klepierre has a trailing twelve months price to earnings ratio of 39.55. meaning, the purchaser of the share is investing €39.55 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.26%.

volatility

klepierre's last week, last month's, and last quarter's current intraday variation average was a positive 0.38%, a negative 0.13%, and a positive 0.83%.

klepierre's highest amplitude of average volatility was 0.43% (last week), 0.55% (last month), and 0.83% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, klepierre's stock is considered to be oversold (<=20).

more news about klepierre.

2. montea (mont.br)

4.13% forward dividend yield and 5.79% return on equity

montea nv is a public regulated real estate company under belgian law (gvv/sir) that specialises in logistical property in belgium, the netherlands, france, and germany. the company is a benchmark player in this market. montea literally offers its customers the space to grow through versatile and innovative property solutions. in this way, montea creates value for its shareholders. as of 30/09/2023 the property portfolio represented a total surface of 1,921,172 m² spread across 94 locations. montea nv has been listed on euronext brussels (mont) and euronext paris (montp) since the end of 2006.

earnings per share

as for profitability, montea has a trailing twelve months eps of €3.82.

pe ratio

montea has a trailing twelve months price to earnings ratio of 20.73. meaning, the purchaser of the share is investing €20.73 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.79%.

sales growth

montea's sales growth is 5% for the ongoing quarter and 25.8% for the next.

yearly top and bottom value

montea's stock is valued at €79.20 at 16:30 est, way under its 52-week high of €88.20 and way higher than its 52-week low of €61.90.

dividend yield

as stated by morningstar, inc., the next dividend payment is on may 19, 2023, the estimated forward annual dividend rate is 3.3 and the estimated forward annual dividend yield is 4.13%.

more news about montea.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com